| Identification | Back Directory | [Name]
Gepotidacin mesylate | [CAS]
1624306-20-2 | [Synonyms]
Gepotidacin mesylate
Gepotidacin mesylate dihydrate
(R)-2-((4-(((3,4-dihydro-2H-pyrano[2,3-c]pyridin-6-yl)methyl)amino)piperidin-1-yl)methyl)-1,2-dihydro-3H,8H-2a,5,8a-triazaacenaphthylene-3,8-dione methanesulfonate dihydrate | [Molecular Formula]
C25H32N6O6S | [MOL File]
1624306-20-2.mol | [Molecular Weight]
544.63 |
| Hazard Information | Back Directory | [Uses]
Gepotidacin mesylate hydrate is an orally active triazaacenaphthylene antibiotic and bacterial type II topoisomerase inhibitor. Gepotidacin mesylate hydrate inhibits bacterial DNA replication by blocking topoisomerase enzymes. Gepotidacin mesylate hydrate selectively inhibits topoisomerase IV and the B subunit of DNA gyrase[1][2]. | [References]
[1] Gibson EG, et al. Mechanistic and Structural Basis for the Actions of the Antibacterial Gepotidacin against Staphylococcus aureus Gyrase. ACS Infect Dis. 2019 Apr 12;5(4):570-581. DOI:10.1021/acsinfecdis.8b00315
[2] Watkins RR, et al. Gepotidacin: a novel, oral, 'first-in-class' triazaacenaphthylene antibiotic for the treatment of uncomplicated urinary tract infections and urogenital gonorrhoea. J Antimicrob Chemother. 2023 May 3;78(5):1137-1142. DOI:10.1093/jac/dkad060 |
|
|